Non-Current Liabilities

Secured Borrowings Cash Right to Reclaim

Over 5 years (FY 2020 to FY 2025), Secured Borrowings Cash Right to Reclaim shows a downward trend with a -100.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ4 2014
Last reportedQ1 2026May 4, 2026
Metric ID: secured_borrowings_cash_right_to_reclaim

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$19.00M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$97.00M$0.00$0.00$0.00
QoQ Change-100.0%-100.0%
YoY Change-100.0%
Range$0.00$97.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Merck & Co.'s secured borrowings cash right to reclaim?
Merck & Co. (MRK) reported secured borrowings cash right to reclaim of $0.00 in Q1 2026.
What is the long-term trend for Merck & Co.'s secured borrowings cash right to reclaim?
Over 5 years (2020 to 2025), Merck & Co.'s secured borrowings cash right to reclaim has grown at a -100.0% compound annual growth rate (CAGR), from $36.00M to $0.00.